Thrombocytes and International Normalized Ratio Are no Predictors for Bleeding in Application of Central Veneous Catheters
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Bleeding
- Sponsor
- Heidelberg University
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Bleeding within 24 hours after cvc application
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
Since many of the patients in an intensive care unit suffer from disorders of hemostasis, bleeding is a main concern applying central venous catheters. Even if there are some data indicating elevated international normalized ratio may not increase the risk of bleeding no clear cut-off has been defined so far. An INR > 1.5 is generally considered to increase the risk of bleeding. Furthermore, many authors consider platelets below 50 x 109 /l as a contra-indication to CVC cannulation, since there are some data this may increase the risk of bleeding. Therefore platelet transfusion before venous puncture is suggested. In our clinical experience INR > 1.5 and platelets < 50 x 109 /l do not correlate with increased risk of bleeding. The aim of this study is to demonstrate, that coagulopathy, defined by INR and platelet count, is not decisive for bleeding.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients acquiring a central venous catheter
Exclusion Criteria
- •Patients pre or post surgery
- •Patients with bleeding due to other reason
Outcomes
Primary Outcomes
Bleeding within 24 hours after cvc application
other complications within the first 24 hours
Secondary Outcomes
- mortality
- long-term complications